Byron Cryer, an expert in gastrointestinal side effects who was a nonvoting adviser to the FDA panel, says that he does not view the decision as being counter to the panel's advice.
The advisory panel could have voted to recommend pulling over-the-counter drugs that use acetaminophen in combination with other ingredients -- such as NyQuil, Pamprin and Allerest -- but it chose not to.